One hundred forty patients (81%) had an identifiable mutation in 1 of the LQTS susceptibility genes, with KCNQ1 (82; 59%), KCNH2 (40; 29%), SCN5A (7; 5%), and compound mutations (8; 6%), representing the largest subsets. The gene discussed is SCN5A; the disease is familial long QT syndrome.